CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 3.92
  • -0.21-5.08%
Market Closed Nov 15 15:00 CST
19.37BMarket Cap-25128P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.54B
--
-41.49%
EPS
--
<0.01
--
--
Analyst Rating
No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Tianmao Group: Report for the third quarter of 2024

    Oct 31 00:00

  • Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

    Oct 15 00:00

  • Tianmao Group: Guohua Life 2024 Semi-Annual Report

    Aug 31 00:00

  • Tianmao Group: 2024 Semi-Annual Report Summary

    Aug 31 00:00

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data